Poluzzi, Elisabetta

Assessing the association of pioglitazone use and bladder cancer through drug adverse event reporting

Piccinni, C., Motola, D., Marchesini, G., & Poluzzi, E. (2011) · Diabetes Care

Pharmacovigilance and Adverse Drug ReactionsMetabolism, Diabetes, and Cancer

Cited by 239

Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems

Cutroneo, P. M., Sartori, D., Tuccori, M., Crisafulli, S., Battini, V., Carnovale, C., Rafaniello, C., Capuano, A., Poluzzi, E., Moretti, U., et al. (2024) · Frontiers in Drug Safety and Regulation

Pharmacovigilance and Adverse Drug ReactionsStatistical Methods in Clinical Trials

Cited by 224

Lessons to be learnt from real-world studies on immune-related adverse events with checkpoint inhibitors: a clinical perspective from pharmacovigilance

Raschi, E., Gatti, M., Gelsomino, F., Ardizzoni, A., Poluzzi, E., & De Ponti, F. (2020) · Targeted Oncology

Cancer Immunotherapy and BiomarkersPharmacovigilance and Adverse Drug Reactions

Cited by 157

Pharmacovigilance of sodium-glucose co-transporter-2 inhibitors: what a clinician should know on disproportionality analysis of spontaneous reporting systems

Raschi, E., Poluzzi, E., Salvo, F., Pariente, A., De Ponti, F., Marchesini, G., & Moretti, U. (2018) · Nutrition, Metabolism and Cardiovascular Diseases

Pharmacovigilance and Adverse Drug ReactionsDiabetes Treatment and Management

Cited by 119

Toxicities with immune checkpoint inhibitors: emerging priorities from disproportionality analysis of the FDA adverse event reporting system

Raschi, E., Mazzarella, A., Antonazzo, I. C., Bendinelli, N., Forcesi, E., Tuccori, M., Moretti, U., Poluzzi, E., & De Ponti, F. (2019) · Targeted Oncology

Cancer Immunotherapy and BiomarkersPharmacovigilance and Adverse Drug Reactions

Cited by 101

Hepatitis B vaccination and the putative risk of central demyelinating diseases – a systematic review and meta-analysis.

Mouchet, J., Salvo, F., Raschi, E., Poluzzi, E., Antonazzo, I. C., De Ponti, F., & Bégaud, B. (2018) · Vaccine

Multiple Sclerosis Research StudiesHepatitis B Virus Studies

Cited by 49

The Changing Face of Drug-induced Adrenal Insufficiency in the Food and Drug Administration Adverse Event Reporting System

Raschi, E., Fusaroli, M., Massari, F., Mollica, V., Repaci, A., Ardizzoni, A., Poluzzi, E., Pagotto, U., & Di Dalmazi, G. (2022) · The Journal of Clinical Endocrinology & Metabolism

Pharmacovigilance and Adverse Drug ReactionsAdrenal Hormones and Disorders

Cited by 17